http://www.cnr.it/ontology/cnr/individuo/prodotto/ID155642

Progetto ARGA \"Allergopatie Respiratorie:studio di monitoraggio delle linee guida Gina ed Aria\" (Rapporti progetti di ricerca)

Type

Rapporti progetti di ricerca (Classe)
Prodotto della ricerca (Classe)

Label

Progetto ARGA \"Allergopatie Respiratorie:studio di monitoraggio delle linee guida Gina ed Aria\" (Rapporti progetti di ricerca) (literal)

Anno

2010-01-01T00:00:00+01:00 (literal)

Alternative label

Sandra Baldacci, Sara Maio, Sonia Cerrai, Anna Angino, Giovanni Viegi, Anna Paola Pala, Megon Bresciani, Pasquale Pierimarchi, Pierluigi Paggiaro, Francesco Forastiere, Daniela Porta, Isa Cerveri, Fabrizio Spinozzi, Fulvio Braido, Walter Canonica, Amelia Filippelli, Marco Santagati, Leonardo Antonicelli, Carlo Pini. (2010)
Progetto ARGA "Allergopatie Respiratorie:studio di monitoraggio delle linee guida Gina ed Aria"
(literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

Sandra Baldacci, Sara Maio, Sonia Cerrai, Anna Angino, Giovanni Viegi, Anna Paola Pala, Megon Bresciani, Pasquale Pierimarchi, Pierluigi Paggiaro, Francesco Forastiere, Daniela Porta, Isa Cerveri, Fabrizio Spinozzi, Fulvio Braido, Walter Canonica, Amelia Filippelli, Marco Santagati, Leonardo Antonicelli, Carlo Pini. (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#note

Project title: Progetto bandi AIFA - Ministero della Salute ricerca indipendente 2005-2007. Project report B.5 studio linee guida, 2006. (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#descrizioneSinteticaDelProdotto

ABSTRACT: Background: asthma is a chronic inflammatory airways disease closely associated with atopic diseases like allergic rhinitis. Both diseases are increasing to epidemic proportions (allergic rhinitis: 10-50%; and asthma: 5-15%) with a reduced patients' quality of life, lower productivity and increasing medical costs. The correct management of asthmatic and rhinitic patients would be ensured by the use of ARIA (Allergic Rhinitis and its Impact on Asthma). Many studies prove that the guidelines recommendations are not or only partially applied within the clinical practice. Further, there are few studies on the control of the disease and on the treatment efficacy in the real life of the general population. Objectives: the general aim is to evaluate the applicability and the adherence/not adherence to the GINA and ARIA guidelines in different care settings and geographic areas in order to orientate AIFA regulatory activity. Methods: the project, planned to last 3 years, is framed in: a) observational studies in General Practitioners (GP), in Hospital pneumologists and allergists, in a birth cohort and in young adults; b) drug surveillance; c) educational intervention; d) prescriptions appropriateness and pharmacoeconomy. Expected results: the project will allow to provide: 1. epidemiological data on asthma and rhinitis burden (prevalence, economic costs); 2. evaluation of applicability, utility and adherence to GINA and ARIA guidelines by GPs, specialists and patients; 3. short term and long term efficacy of a Continuing Professional Development program (knowledge improvement, adherence to the guidelines, changes in disease direct costs); 4. evaluation of prescriptions appropriateness and treatment cost/efficacy ratio (beclometasone, flunisolide, budesonide, acetilcisteina, drugs associations). The following expected results will be able to contribute to AIFA regulatory activity: 1. adherence to the AIFA notes concerning anti-leukotriene and anti-histamine drugs prescriptions (notes 82 and 89); 2. quality evaluation of allergenic extracts utilized in specific immunotherapy (SIT); 3. regional reimbursement modalities for SIT; 4. use of self-inject able adrenaline in emergency department for regulation of Fast Jet Adrenaline; 5. use of unconventional therapies; 6. regional utilization of generic drugs in the place of branded drugs with expired patent. (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#supporto

Altro (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

Institute of Clinical Physiology (IFC), CNR, Pisa, Italy; Clinical and Experimental Medicine Department, Internal Medicine, University of Perugia, Italy; Cardio-Thoracic Department, University of Pisa, Italy; IRCCS San Matteo Hospital Foundation, University of Pavia, Italy; Department of Epidemiology, Rome Health Authority, Italy; Rome Local Health Service, SIFO (Italian Society of Clinical Pharmacy), Italy; Pharmacology Department, 2nd University of Naples, Italy; Department of Pulmonary Diseases, University of Genoa, Italy; Internal Medicine, Immuno-Allergic and Respiratory Department, AAITO, Ancona, Italy; Department of Immunology, Istituto Superiore di Sanità, Rome, Italy. (literal)

Titolo